{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:21:15Z","timestamp":1761517275837,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.4158\/ep.2.3.215","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:24:55Z","timestamp":1365204295000},"page":"215-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevention and Treatment of Diabetic Nephropathy: Role of Angiotensin-Converting Enzyme Inhibitors"],"prefix":"10.1016","volume":"2","author":[{"given":"Finnbogi O.","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.2.3.215_bb0005","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/diacare.17.11.1357","volume":"17","author":"Consensus Development Conference on the Diagnosis and Management of Nephropathy in Patients With Diabetes Mellitus","year":"1994","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.2.3.215_bb0010","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2337\/diacare.16.10.1394","article-title":"American Diabetes Association Treatment of hypertension in diabetes","volume":"16","author":"Statement","year":"1993","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.2.3.215_bb0015","series-title":"Lebovitz HE","article-title":"Nephropathy","author":"Defronzo","year":"1994"},{"issue":"Suppl 2","key":"10.4158\/EP.2.3.215_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diab.32.2.S64","article-title":"The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy","volume":"32","author":"Mogensen","year":"1983","journal-title":"Diabetes."},{"key":"10.4158\/EP.2.3.215_bb0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9343(85)90284-0","article-title":"The changing natural history of nephropathy in type I diabetes","volume":"78","author":"Krolewski","year":"1985","journal-title":"Am J Med."},{"key":"10.4158\/EP.2.3.215_bb0030","series-title":"Ellenberg and Rifkin\u2019s Diabetes Mellitus: Theory and Practice","first-page":"684","article-title":"Diabetic renal disease","author":"Friedman","year":"1990"},{"key":"10.4158\/EP.2.3.215_bb0035","first-page":"977","article-title":"The effect of intensive diabetes management on long-term complications in insulin dependent diabetes mellitus","volume":"310","author":"DCCT Research Group","year":"1993","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.2.3.215_bb0040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ki.1988.51","article-title":"Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats","volume":"33","author":"Kasiske","year":"1988","journal-title":"Kidney Int."},{"key":"10.4158\/EP.2.3.215_bb0045","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1001\/jama.1990.03440140080036","article-title":"The natural history and epidemiology of diabetic nephropathy","volume":"263","author":"Shelby","year":"1990","journal-title":"JAMA."},{"key":"10.4158\/EP.2.3.215_bb0050","series-title":"and Blood Institute","article-title":"National Heart, Lung","author":"The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD","year":"1993"},{"key":"10.4158\/EP.2.3.215_bb0055","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1681\/ASN.V371333","article-title":"Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatment also help to improve renal function outcome?","volume":"3","author":"de Jong","year":"1993","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP.2.3.215_bb0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1989.227","article-title":"Short and long term effects in antihypertensive therapy in the diabetic rat","volume":"36","author":"Anderson","year":"1989","journal-title":"Kidney Int."},{"key":"10.4158\/EP.2.3.215_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3349\/ymj.1992.33.3.217","article-title":"Amelioration of diabetic proteinuria and lipid peroxidation by captopril","volume":"33","author":"Ha","year":"1992","journal-title":"Yonsei Med J."},{"key":"10.4158\/EP.2.3.215_bb0070","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI112521","article-title":"Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension","volume":"77","author":"Zats","year":"1986","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.2.3.215_bb0075","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005344-198706000-00010","article-title":"Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy and streptozocin induced diabetes in the rat","volume":"9","author":"Jackson","year":"1987","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.4158\/EP.2.3.215_bb0080","first-page":"5","article-title":"Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat","volume":"1","author":"Cooper","year":"1988","journal-title":"J Hypertens."},{"key":"10.4158\/EP.2.3.215_bb0085","first-page":"861","article-title":"Effects of angiotensin converting enzyme inhibition in diabetic rats with reduced renal function","volume":"120","author":"Geiger","year":"1992","journal-title":"J Lab Clin Med."},{"key":"10.4158\/EP.2.3.215_bb0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF00265552","article-title":"Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat","volume":"32","author":"Cooper","year":"1989","journal-title":"Diabetologia."},{"key":"10.4158\/EP.2.3.215_bb0095","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2337\/diab.39.12.1575","article-title":"Nephropathy in model combining genetic hypertension with experimental diabetes: enalapril versus hydralazine and metoprolol therapy","volume":"39","author":"Cooper","year":"1990","journal-title":"Diabetes."},{"key":"10.4158\/EP.2.3.215_bb0100","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2337\/diab.41.9.1106","article-title":"Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat","volume":"41","author":"Ellis","year":"1992","journal-title":"Diabetes."},{"key":"10.4158\/EP.2.3.215_bb0105","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198806233182505","article-title":"The progression of renal disease","volume":"318","author":"Klahr","year":"1988","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.2.3.215_bb0110","first-page":"69","article-title":"Remnant kidney hypermetabolism and progression of chronic renal failure","volume":"81","author":"Harris","year":"1988","journal-title":"Am J Physiol."},{"key":"10.4158\/EP.2.3.215_bb0115","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.2.3.215_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","article-title":"Pauls JF (for the European Microalbuminuria Captopril Study Group). Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria","volume":"271","author":"Viberti","year":"1994","journal-title":"JAMA."},{"key":"10.4158\/EP.2.3.215_bb0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.299.6698.533","article-title":"Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy","volume":"299","author":"Parving","year":"1989","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-3476(05)82441-2","article-title":"Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin dependent diabetes mellitus","volume":"117","author":"Cook","year":"1990","journal-title":"J Pediatr."},{"key":"10.4158\/EP.2.3.215_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.303.6794.81","article-title":"Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetics with microalbuminuria","volume":"303","author":"Mathiesen","year":"1991","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/oxfordjournals.ndt.a092431","article-title":"Renal responses to nifedipine and captopril in hypertensive insulin dependent diabetic men: a randomized cross-over study","volume":"8","author":"Jenkins","year":"1990","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP.2.3.215_bb0145","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.297.6656.1092","article-title":"Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria","volume":"297","author":"Marre","year":"1988","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/bmj.298.6669.284","article-title":"Short term effects of captopril on microalbuminuria induced by exercise in normotensive diabetics","volume":"298","author":"Romanelli","year":"1989","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0155","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198512263132601","article-title":"Effect of captopril on heavy proteinuria in azotemic diabetes","volume":"313","author":"Taguma","year":"1985","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.2.3.215_bb0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.304.6823.339","article-title":"Renal protective effect of enalapril in diabetic nephropathy","volume":"304","author":"Bjorck","year":"1992","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0165","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/archinte.1987.00370080033008","article-title":"Renal protective effect of strict blood pressure control with enalapril therapy","volume":"147","author":"Bauer","year":"1987","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.2.3.215_bb0170","first-page":"463","article-title":"Comparative effects of antihypertensive agents upon incipient and overt diabetic nephropathy","volume":"17","author":"Freire","year":"1991","journal-title":"Hypertension."},{"key":"10.4158\/EP.2.3.215_bb0175","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.300.6729.904","article-title":"Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy","volume":"300","author":"Bjorck","year":"1990","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0272-6386(12)70256-1","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy","volume":"20","author":"Bauer","year":"1992","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.2.3.215_bb0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00004872-198811000-00011","article-title":"Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy","volume":"6","author":"Mimran","year":"1988","journal-title":"J Hypertens."},{"key":"10.4158\/EP.2.3.215_bb0190","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1464-5491.1988.tb01052.x","article-title":"Acute and long term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin dependent diabetic patients","volume":"5","author":"Pedersen","year":"1988","journal-title":"Diabet Med."},{"key":"10.4158\/EP.2.3.215_bb0195","first-page":"18","article-title":"Short term effect of angiotensin converting enzyme inhibitor enalapril in incipient diabetic nephropathy","volume":"31","author":"Abu","year":"1989","journal-title":"Clin Nephrol."},{"key":"10.4158\/EP.2.3.215_bb0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00285294","article-title":"Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltrating type 1 (insulin dependent) diabetic children","volume":"32","author":"Drummond","year":"1989","journal-title":"Diabetologia."},{"key":"10.4158\/EP.2.3.215_bb0205","first-page":"149","article-title":"The effect of enalapril on the development of diabetic nephropathy in children and adolescents","volume":"46","author":"Lebl","year":"1991","journal-title":"Cesk Pediatr."},{"key":"10.4158\/EP.2.3.215_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bmj.306.6871.175","article-title":"Comparison in reduction of microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes","volume":"306","author":"Hallab","year":"1993","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0215","first-page":"19","article-title":"Enalapril in patients with diabetes mellitus type I with microalbuminuria without hypertension","volume":"48","author":"Semetkowska","year":"1993","journal-title":"Pol Tyg Lek."},{"key":"10.4158\/EP.2.3.215_bb0220","first-page":"327","article-title":"Placebo controlled trial with lisinopril in normotensive diabetic patients with incipient nephropathy","volume":"7","author":"O\u2019Donnell","year":"1993","journal-title":"J Hum Hypertens."},{"key":"10.4158\/EP.2.3.215_bb0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.16.4.597","article-title":"Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin converting enzyme inhibitors","volume":"16","author":"Romero","year":"1993","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.2.3.215_bb0230","first-page":"181","article-title":"Enalapril and microalbuminuria in diabetic and non-diabetic hypertension","volume":"1","author":"Kelleher","year":"1987","journal-title":"J Hum Hypertens."},{"issue":"Suppl 7","key":"10.4158\/EP.2.3.215_bb0235","doi-asserted-by":"crossref","first-page":"s314","DOI":"10.1097\/00004872-198900076-00153","article-title":"Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria","volume":"7","author":"Stornello","year":"1989","journal-title":"J Hypertens."},{"key":"10.4158\/EP.2.3.215_bb0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.2.3.215_bb0245","series-title":"Heart Disease: A Textbook of Cardiovascular Medicine","first-page":"817","article-title":"Systemic hypertension: mechanism and diagnosis","author":"Kaplan","year":"1994"},{"key":"10.4158\/EP.2.3.215_bb0250","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/jama.1967.03130140068008","article-title":"Some aspects of hypertension in diabetes mellitus","volume":"202","author":"Pell","year":"1967","journal-title":"JAMA."},{"year":"1993","series-title":"Medical Management of Pregnancy Complicated by Diabetes","author":"American Diabetes Association","key":"10.4158\/EP.2.3.215_bb0255"},{"key":"10.4158\/EP.2.3.215_bb0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bmj.302.6770.210","article-title":"Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria","volume":"302","author":"Melbourne Diabetic Nephropathy Study Group","year":"1991","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00265402","article-title":"Comparison of the renal effect of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulindependent) diabetic patients with microalbuminuria","volume":"32","author":"Baba","year":"1989","journal-title":"Diabetologia."},{"key":"10.4158\/EP.2.3.215_bb0270","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/bmj.305.6860.981","article-title":"Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension","volume":"305","author":"Chan","year":"1992","journal-title":"BMJ."},{"key":"10.4158\/EP.2.3.215_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0891-6632(91)90058-W","article-title":"Effects of angiotensin converting enzyme inhibitor (alacepril) and calcium antagonist (nicardipine) in hypertensive non-insulin-dependent diabetic patients with microalbuminuria","volume":"5","author":"Haisa","year":"1991","journal-title":"J Diabetic Complications."},{"issue":"Suppl 5","key":"10.4158\/EP.2.3.215_bb0280","first-page":"s269","article-title":"Progression of renal disease: effects of different classes of antihypertensive therapy","volume":"4","author":"Jackson","year":"1986","journal-title":"J Hypertens."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/4DL4B3BCP4KD195W.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:16:06Z","timestamp":1761516966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20429945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["S1530891X20429945"],"URL":"https:\/\/doi.org\/10.4158\/ep.2.3.215","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[1996,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and Treatment of Diabetic Nephropathy: Role of Angiotensin-Converting Enzyme Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.2.3.215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}